Triplet therapy of telmisartan, amlodipine, and indapamide shows superior blood pressure control in hypertension management
1. Mean reduction in home systolic blood pressure at 12 weeks was greater with GMRx2 than with dual combination therapy. 2. Clinic blood pressure control was superior with GMRx2. Evidence Rating Level: 1 (Excellent) Study Rundown: Single-pill combinations (SPCs) of...